Christian Schmithals
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Assessment of the Pharmacokinetics, Disposition, and Duration of Action of the Tumour-Targeting Peptide CEND-1.
Journal: International journal of molecular sciences
Published: February 20, 2023
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapy.
Journal: Hepatology (Baltimore, Md.)
Published: February 09, 2022
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors.
Journal: Cancers
Published: November 19, 2021
Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model.
Journal: International journal of cancer
Published: March 17, 2020
Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis.
Journal: Scientific reports
Published: December 04, 2019
Selective targeting of tumor associated macrophages in different tumor models.
Journal: PloS one
Published: September 28, 2017
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.
Journal: ACS chemical biology
Published: January 04, 2017
Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial-Mesenchymal Transition.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2016
Vesicle-associated microRNAs are released from blood cells on incubation of blood samples.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: September 22, 2015
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Journal: Cancer research
Published: August 05, 2015
Last Updated: 09/26/2026